Artigo Revisado por pares

Everything everywhere all at once

2023; American Association for the Advancement of Science; Volume: 8; Issue: 87 Linguagem: Inglês

10.1126/sciimmunol.adk4486

ISSN

2470-9468

Autores

Asha Pillai,

Tópico(s)

Monoclonal and Polyclonal Antibodies Research

Resumo

In successful melanoma immunotherapy, clonal TCRs can recognize multiple tumor-specific antigens simultaneously through cross-reactivity.

Referência(s)
Altmetric
PlumX